Gene Patents: Incentive or Impediment for Pharmaceutical Innovation?
DOI:
https://doi.org/10.37381/ersdsb53Abstract
This research explores biopharmaceutical companies’ behavior of obtaining patent
protection under the tightened patentability standard for biotechnology innovation. To explore the
importance of innovations, we collected time-series data from twenty firms over two decades and
examined the role of biotechnology on a firm’s operating performance and profit via an empirical
regression model. The results suggest that greater R&D investment brings firms higher revenue and
profit, but a more influential patent does not seem to reward all companies. The possession of
biotechnology can help companies increase revenue. For large-scale R&D firms, marketing
involvement is particularly important to boost revenue, but low-scale R&D firms should avoid
having a high ratio of biotechnology in their patent portfolio strategy.